[1]么俊鹏,马显军.活血化瘀药治疗糖尿病下肢血管病变疗效的Meta分析[J].医学信息,2021,34(18):78-83.[doi:10.3969/j.issn.1006-1959.2021.18.021]
　YAO Jun-peng,MA Xian-jun.Meta-analysis of the Curative Effect of Huoxuehuayu Drugs inTreating Diabetic Lower Extremity Vascular Disease[J].Medical Information,2021,34(18):78-83.[doi:10.3969/j.issn.1006-1959.2021.18.021]
点击复制

活血化瘀药治疗糖尿病下肢血管病变疗效的Meta分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年18期
页码:
78-83
栏目:
论著
出版日期:
2021-09-18

文章信息/Info

Title:
Meta-analysis of the Curative Effect of Huoxuehuayu Drugs inTreating Diabetic Lower Extremity Vascular Disease
文章编号:
1006-1959（2021）18-0078-06
作者:
么俊鹏1; 马显军2
天津市宁河区中医医院脑病科1，心血管糖尿病科2，天津 301500
Author(s):
YAO Jun-peng1; MA Xian-jun2
Department of Cardiovascular Diabetes1,Department of Encephalopathy2,Tianjin Ninghe District TraditionalChinese Medicine Hospital,Tianjin 301500,China
关键词:
糖尿病; 下肢血管病变; 活血化瘀药
Keywords:
Diabetes; Lower limb vascular disease; Huoxuehuayu drugs
分类号:
R259
DOI:
10.3969/j.issn.1006-1959.2021.18.021
文献标志码:
A
摘要:
目的 系统评价活血化瘀药治疗糖尿病下肢血管病变的临床疗效。方法 计算机检索CNKI、CBM、Pubmed、Embase、Cochrane等数据库中有关活血化瘀药治疗糖尿病下肢血管病变的相关文献，时间设置建库至2020年12月31日，筛选符合条件的文献，分析活血化瘀药治疗糖尿病下肢血管病变的效果。结果 最终纳入12篇文献，各研究无异质性（P＞0.1，I2＜40%），采用固定效应模型分析；Meta分析显示，中药组临床疗效优于对照组（OR=4.13，95%CI：2.95~5.79，P＜0.05），且漏斗图和Egger检验显示各研究间无明显发表偏移。结论 活血化瘀药治疗糖尿病下肢血管病变的临床疗效可靠，但需要临床进一步了解此类中药的作用。
Abstract:
Objective To systematically evaluate the clinical efficacy of Huoxuehuayu drugs in treating diabetic lower extremity vascular disease.Methods A computer search of the relevant literature on the treatment of diabetic lower extremity vascular diseases with Huoxuehuayu drugs in CNKI, CBM, Pubmed, Embase, Cochrane, etc.The time was set to build the database until December 31, 2020. The documents that met the conditions were screened and the effect of Huoxuehuayu drugs on the treatment of diabetic lower extremity vascular diseases was analyzed.Results Twelve articles were finally included, and there was no heterogeneity in each study (P>0.1, I2<40%), and the fixed effects model was adopted;Meta-analysis showed that the clinical efficacy of the Chinese medicine group was better than that of the control group （OR=4.13，95%CI：2.95-5.79，P＜0.05）, and the funnel plot and Egger test showed that there was no significant publication deviation between the studies.Conclusion The clinical efficacy of Huoxuehuayu drugs in treating diabetic lower extremity vascular disease is reliable, but further clinical understanding of the role of such traditional Chinese medicines is needed.

参考文献/References:

[1]中国医疗保健国际交流促进会糖尿病足病分会.中国糖尿病足诊治指南[J].中华医学杂志,2017,97(4):251-258.[2]闫涛.凉润通络汤佐治2型糖尿病并周围动脉病变早期疗效观察[J].中医药学报,2010,38(4):84-86.[3]姜涛文,祯姜敏,卢桂阳.中西医结合治疗糖尿病下肢动脉病变介入术后再狭窄的临床研究[J].中国中西医结合杂志,2011,31(2):182-187.[4]邓建华.补阳还五汤联合空气波压力治疗仪治疗糖尿病足0级53例[J].辽宁中医杂志,2014,41(7):1443-1445.[5]李清云.活血通络方足浴配合护理干预在糖尿病足0级患者中的应用效果[J].临床合理用药杂志,2016,9(3):119-120.[6]刘进.益气扶正活血化淤中药熏洗联合前列地尔和辛伐他汀治疗糖尿病下肢动脉血管病变的疗效观察[J].中国实用乡村医生杂志,2016,23(7):57-60.[7]陈洪艳,肇颖斌,徐光,等.活血止痛散联合西药治疗早期糖尿病足的临床观察[J].上海中医药杂志,2017,51(9):53-56.[8]郭梅珍,李高申.干细胞移植联合活血生肌汤治疗糖尿病足伴下肢慢性缺血的疗效[J].中国老年学杂志,2017,37(13):3198-3200.[9]陈焱,白清,孙新宇.益气活血通脉法治疗糖尿病下肢动脉粥样硬化性病变的临床观察[J].中国实验方剂学杂志,2019,25(11):103-108.[10]李杰,邓宏平.逐瘀通脉胶囊联合法舒地尔对2型糖尿病下肢动脉硬化闭塞症患者疗效及应激状态的影响[J].武汉大学学报（医学版）,2019,40(2:270-274.[11]唐敏,胡苹.化瘀通痹汤联合盐酸沙格雷酯片治疗老年2型糖尿病合并下肢动脉硬化闭塞症临床研究[J].国际中医中药杂志,2019,41(7):702-705.[12]赵金超,杜玉青,李创,等.活血通脉法干预糖尿病下肢血管病介入术后支架内再狭窄的疗效观察[J].北京中医药,2020,39(6):526-530.[13]陈铁林,屠伟平.通络活血方沐足结合常规西医疗法治疗气虚血瘀型糖尿病足临床研究[J].新中医,2020,52(03):66-69.[14]李洪基.糖尿病周围神经病变的中医证型及相关因素研究[D].沈阳:辽宁中医药大学,2016.[15]赵红霞,白文静,贾海骅,等.304篇糖尿病中医证候文献分析[J].中国中医基础医学杂志,2012,18(8):834-835.[16]刘志龙,李锡杰,丁萍,等.2型糖尿病中医证型的筛选研究[J].新中医,2008,40(12):23-25.[17]卫燕文,柳国斌.糖尿病足的中医证型分析[J].辽宁中医杂志,2011,38(1):27-29.[18]南茜,柳红芳,陈香美,等.2型糖尿病患者中医证素和糖化血红蛋白水平关系的研究[J].中华中医药杂志,2019,34(7):3190-3193.[19]张文佳,付晓乐,辛效毅.2型糖尿病中医证型与临床生化指标的关系[J].南京中医药大学学报,2017,33(5):484-487.[20]庞国明,孙扶.2型糖尿病中医证型与动态血糖变化相关性的临床研究[J].中华中医药杂志,2017,32(3):1384-1386.[21]赵佩亮,王园园,王乾,等.糖尿病下肢血管病变中医证型与彩色多普勒超声结果的相关性研究[J].中华中医药学刊,2016,34(12):3050-3052.[22]钱秋海.活血化瘀防治糖尿病及并发症机制探讨[J].山东中医杂志,2002(3):131-133.[23]黄兆胜.中药学[M].北京:中国中医药出版社,2002.[24]孟德阳.活血化瘀中药药理的作用探究[J].北方药学,2017,14(12):142-143.[25]何莉,孙汉英,刘文励,等.川芎嗪对同基因骨髓移植小鼠骨髓中干细胞因子表达的影响[C]//中华医学会血液学分会.中华医学会第八次全国血液学学术会议论文汇编.2004.[26]段贤春.基于网络药理学与转录组学探索桃红四物汤治疗缺血性中风主要物质基础及作用机制[D].合肥:安徽中医药大学,2020.[27]徐辉辉,李索咪,范梦强,等.富血小板血浆联合桃红四物汤对激素性股骨头坏死大鼠股骨头组织VEGF,CD31,ALP,β-catenin蛋白表达的影响[J].中华中医药杂志,2020,35(3): 1501-1504.[28]章春生,刘锌,杜斌,等.基于数据挖掘的中医药治疗糖皮质激素相关型股骨头坏死用药规律分析[J].辽宁中医杂志, 2020,19(8):35-40.[29]沈忱.基于贝叶斯网络数据挖掘技术研究《本草纲目》活血化瘀类中药性-效-用关系[D].南京:南京中医药大学,2015.[30]吕仕超,张军平.活血化瘀中药与抗血小板药物联用治疗冠心病的研究[C]//中国南方各省市心血管病专业委员会、港澳台地区心血管病专科学院.2014.[31]陈焱,白清,孙新宇.益气活血通脉法治疗糖尿病下肢动脉粥样硬化性病变的临床观察[J].中国实验方剂学杂志,2019,25(11):103-108.[32]朱正花.活血通络方辨证加减治疗血瘀型糖尿病下肢血管病变临床价值分析[J].糖尿病新世界,2018,21(9):180-182.[33]吴迪.评价活血化瘀中药足浴对于糖尿病踝肱指数的影响[J].糖尿病新世界,2016,19(18):67-68.[34]张红.舒洛地特联合辛伐他汀治疗糖尿病下肢血管病变的疗效观察[J].中国急救医学,2016,36(2):35-36.[35]沈世凯,吴丹明,王成刚,等.严重下肢动脉闭塞性疾病旁路移植术和腔内治疗技术的荟萃分析[J].中华医学杂志,2017,97(30):2372-2378.

相似文献/References:

[1]张西园.糖尿病与结直肠癌患者预后相关研究进展[J].医学信息,2018,31(01):55.[doi:10.3969/j.issn.1006-1959.2018.01.020]
　ZHANG Xi-yuan.Research Progress in the Relationship between Diabetes and the Prognosis of Colorectal Cancer[J].Medical Information,2018,31(18):55.[doi:10.3969/j.issn.1006-1959.2018.01.020]
[2]耿金萍.综合护理对甲状腺良性肿瘤并糖尿病患者手术效果的影响分析[J].医学信息,2018,31(01):163.[doi:10.3969/j.issn.1006-1959.2018.01.064]
　GENG Jin-ping.Analysis of the Effect of Comprehensive Nursing on the Surgical Effect of Thyroid Benign Tumor and Diabetic Patients[J].Medical Information,2018,31(18):163.[doi:10.3969/j.issn.1006-1959.2018.01.064]
[3]李雯婷,谈世华,余江明,等.踝肱指数检测在住院糖尿病患者中的重复性研究[J].医学信息,2018,31(03):159.[doi:10.3969/j.issn.1006-1959.2018.03.058]
　LI Wen-ting,TAN Shi-hua,YU Jiang-ming,et al.Study on Reproducibility of Ankle-brachial Index in Inpatients with Diabetes Mellitus[J].Medical Information,2018,31(18):159.[doi:10.3969/j.issn.1006-1959.2018.03.058]
[4]刘 静.冠状动脉粥样硬化性心脏病合并糖尿病的血脂检验结果分析[J].医学信息,2018,31(04):154.[doi:10.3969/j.issn.1006-1959.2018.04.057]
　LIU Jing.Analysis of Blood Lipid Test Results in Coronary Atherosclerotic Heart Disease Complicated with Diabetes Mellitus[J].Medical Information,2018,31(18):154.[doi:10.3969/j.issn.1006-1959.2018.04.057]
[5]谢勇丽,苏晓清,张雅薇.糖尿病痛性周围神经病变患者情绪调查分析[J].医学信息,2018,31(05):14.[doi:10.3969/j.issn.1006-1959.2018.05.005]
　XIE Yong-li,SU Xiao-qing,ZHANG Ya-wei.Investigation and Analysis of Mood in Patients with Diabetic Peripheral Neuropathy[J].Medical Information,2018,31(18):14.[doi:10.3969/j.issn.1006-1959.2018.05.005]
[6]张雅薇,朱明慧.首发为动眼神经麻痹的糖尿病合并动眼神经麻痹误诊为痛性眼肌麻痹1例分析[J].医学信息,2018,31(05):23.[doi:10.3969/j.issn.1006-1959.2018.05.008]
　ZHANG Ya-wei,ZHU Ming-hui.An Analysis of a Case of Diabetes Mellitus with Oculomotor Nerve Palsy Misdiagnosed as Painful Ophthalmoplegia[J].Medical Information,2018,31(18):23.[doi:10.3969/j.issn.1006-1959.2018.05.008]
[7]张宇宁.黄酮类化合物治疗糖尿病及其并发症的研究[J].医学信息,2018,31(05):50.[doi:10.3969/j.issn.1006-1959.2018.05.018]
　ZHANG Yu-ning.Study on Flavonoids in the Treatment of Diabetes Mellitus and its Complications[J].Medical Information,2018,31(18):50.[doi:10.3969/j.issn.1006-1959.2018.05.018]
[8]柳 梅.头孢哌酮钠舒巴坦钠治疗糖尿病并发尿路感染的 临床效果观察[J].医学信息,2018,31(07):139.[doi:10.3969/j.issn.1006-1959.2018.07.047]
　LIU Mei.Clinical Efficacy of Cefoperazone Sodium and Sulbactam Sodium in Treatment of Diabetes Complicated with Urinary Tract Infection[J].Medical Information,2018,31(18):139.[doi:10.3969/j.issn.1006-1959.2018.07.047]
[9]吕桂英.影响糖尿病患者药物治疗依从性相关因素临床分析[J].医学信息,2018,31(08):109.[doi:10.3969/j.issn.1006-1959.2018.08.036]
　LV Gui-ying.Clinical Analysis of Factors Related to Compliance with Drug Therapy in Patients with Diabetes Mellitus[J].Medical Information,2018,31(18):109.[doi:10.3969/j.issn.1006-1959.2018.08.036]
[10]刘爱君.糖化血红蛋白测定在糖尿病诊断中的应用价值分析[J].医学信息,2018,31(08):161.[doi:10.3969/j.issn.1006-1959.2018.08.057]
　LIU Ai-jun.Analysis of the Value of Determination of Glycosylated Hemoglobin in the Diagnosis of Diabetes Mellitus[J].Medical Information,2018,31(18):161.[doi:10.3969/j.issn.1006-1959.2018.08.057]

更新日期/Last Update: 1900-01-01